UPLOAD Filing
Enveric Biosciences, Inc.
Date: Sept. 30, 2025 · CIK: 0000890821 · Accession: 0000000000-25-010725
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290580
Letter
September 30, 2025 Joseph Tucker, Ph.D. Chief Executive Officer Enveric Biosciences, Inc. 245 First Street, Riverview II, 18th Floor Cambridge, MA, 02142 Re:Enveric Biosciences, Inc. Registration Statement on Form S-3 Filed September 29, 2025 File No. 333-290580 Dear Joseph Tucker Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Bradley J. Wyatt, Esq.
Show Raw Text
September 30, 2025
Joseph Tucker, Ph.D.
Chief Executive Officer
Enveric Biosciences, Inc.
245 First Street, Riverview II, 18th Floor
Cambridge, MA, 02142
Re:Enveric Biosciences, Inc.
Registration Statement on Form S-3
Filed September 29, 2025
File No. 333-290580
Dear Joseph Tucker Ph.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Bradley J. Wyatt, Esq.